AIM ImmunoTech Inc (AIM)

Nov 21, 2025

What analyst consensus implies for AIM ImmunoTech Inc. (HXB) stock2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

Why global investors buy AIM ImmunoTech Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Why AIM ImmunoTech Inc. stock fits value portfoliosJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com

Nov 20, 2025

Nov 20, 2025

Will AIM ImmunoTech Inc. (HXB) stock deliver stable dividends2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

How AIM ImmunoTech Inc. (HXB) stock behaves under inflation pressureMarket Movers & Real-Time Chart Breakout Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Is AIM ImmunoTech Inc. (HXB) stock vulnerable to rate hikesQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Can AIM ImmunoTech Inc. stock deliver strong annual returnsJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Is AIM ImmunoTech Inc. stock a buy on weaknessJuly 2025 Movers & Real-Time Volume Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

Can AIM ImmunoTech Inc. (HXB) stock resist broad market declines2025 Market Outlook & Technical Pattern Alert System - newser.com

Nov 19, 2025

Nov 19, 2025

Is AIM ImmunoTech Inc. (HXB) stock bottoming after sell offGDP Growth & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025

Nov 19, 2025

AIM ImmunoTech Enters Note Purchase Agreement - TipRanks

Nov 19, 2025

Nov 19, 2025

Aim ImmunoTech enters Note Purchase Agreement with Streeterville Capital, says SEC filing - MarketScreener

Nov 19, 2025

Nov 19, 2025

Is AIM ImmunoTech Inc. stock a buy before new product rollout2025 Price Targets & Precise Trade Entry Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com

Nov 19, 2025

Nov 18, 2025

AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program - The Manila Times

Nov 18, 2025

Nov 18, 2025

AIM ImmunoTech reports third quarter 2025 financial results and highlights continued progress across pipeline with strategic focus on pancreatic cancer clinical program - MarketScreener

Nov 18, 2025

Nov 18, 2025

AIM ImmunoTech (NYSE American: AIM) Q3 2025 highlights pancreatic cancer Ampligen program, $2.4M cash - Stock Titan

Nov 18, 2025

Nov 17, 2025

AIM ImmunoTech Reports Q3 2025 Financial Results - TipRanks

Nov 17, 2025

Nov 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Nov 17, 2025

Nov 17, 2025

Can AIM ImmunoTech Inc. stock expand revenue streamsWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com

Nov 17, 2025